
Sanara MedTech Inc.: updates and filings
Price
$32.55
November 20, 2026Market cap $298M
What Ploutos Investor adds for Sanara MedTech
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 12, 2026next Feb 11, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 12, 2026FilingForm425
- Nov 12, 2026Results of operationsForm8-K
- Nov 9, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 29, 2026Regulation FD disclosureForm8-K
- Oct 28, 2026FilingForm425
- Oct 16, 2026CURRENT REPORTForm425
- Oct 16, 2026Other material eventsForm8-K
- Oct 16, 2026CURRENT REPORTForm425
- Oct 1, 2026Shareholder vote, other material eventsForm8-K
- Sep 4, 2026Merger meeting proxy statementFormDEFM14A
- Aug 20, 2026FilingForm425
- Aug 11, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 11, 2026FilingForm425
- Aug 11, 2026FilingForm425
- Aug 11, 2026Results of operationsForm8-K
- Aug 11, 2026FilingForm425
- Aug 11, 2026Material agreement entered, Regulation FD disclosure (amendment)Form8-K/A
- Jul 31, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 30, 2026FilingForm425
- Jul 30, 2026FilingForm425
- Jul 30, 2026FilingForm425
- Jul 30, 2026FilingForm425
- Jul 30, 2026FilingForm425
- Jul 30, 2026FilingForm425
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 12, 2026 | 425 | Filing | Document |
| Nov 12, 2026 | 8-K | Results of operations | Document |
| Nov 9, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 29, 2026 | 8-K | Regulation FD disclosure | Document |
| Oct 28, 2026 | 425 | Filing | Document |
| Oct 16, 2026 | 425 | CURRENT REPORT | Document |
| Oct 16, 2026 | 8-K | Other material events | Document |
| Oct 16, 2026 | 425 | CURRENT REPORT | Document |
| Oct 1, 2026 | 8-K | Shareholder vote, other material events | Document |
| Sep 4, 2026 | DEFM14A | Merger meeting proxy statement | Document |
| Aug 20, 2026 | 425 | Filing | Document |
| Aug 11, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 11, 2026 | 425 | Filing | Document |
| Aug 11, 2026 | 425 | Filing | Document |
| Aug 11, 2026 | 8-K | Results of operations | Document |
| Aug 11, 2026 | 425 | Filing | Document |
| Aug 11, 2026 | 8-K/A | Material agreement entered, Regulation FD disclosure (amendment) | Document |
| Jul 31, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 30, 2026 | 425 | Filing | Document |
| Jul 30, 2026 | 425 | Filing | Document |
| Jul 30, 2026 | 425 | Filing | Document |
| Jul 30, 2026 | 425 | Filing | Document |
| Jul 30, 2026 | 425 | Filing | Document |
| Jul 30, 2026 | 425 | Filing | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 2, 1996.
The full analysis
What do Sanara MedTech's filings show?
The filings are where every one of Sanara MedTech's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.